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Silica (silicon dioxide) occupational exposure has been linked to both pulmonary and extra-pulmonary
toxicity. Silicosis is the major pulmonary toxicity, which has also been associated with the develop-
ment of collagen-vascular disease and with anti-neutrophil cytoplasmic antibody (ANCA)-positive
vasculitis, especially perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA). The most common
pulmonary manifestations of microscopic polyangitis (MPA) are interstitial ﬁbrosis and alveolar hem-
orrhage. We describe a patient who had unusual presentation of microscopic polyangitis, characterized
by lung hemorrhage, rapidly progressive glomerulonephritis, pleuropericarditis and pulmonary embo-
lism that was associated with a history of silica exposure and radiologic evidence for silicosis.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Occupational exposures to silica dust has been linked to both
pulmonary and extra-pulmonary toxicity [1e6]. The major pul-
monary toxicity is silicosis. Silicosis has also been associated with
the development of collagen-vascular disease and with anti-
neutrophil cytoplasmic antibody (ANCA)-positive vasculitis, espe-
cially anti-myeloperoxidase (MPO) antibody [1,7]. The most com-
mon pulmonary manifestations of microscopic polyangiitis (MPA)
are interstitial ﬁbrosis and alveolar hemorrhage [8]. We describe a
patient who had microscopic polyangiitis, characterized by lung
hemorrhage, pulmonary embolism and pleuropericarditis that was
associated with a history of silica exposure and radiologic evidence
for silicosis.2. Case report
A 68-year-old man reported a 2-week history of dry cough with
a central chest discomfort radiating to the epigastrium. There was
no associated hemoptysis, breathlessness or palpitations. He was. Al-Rajhi), elisa.brega@mail.
man).
Ltd. This is an open access article useen in another institution 11 days prior to admissionwhere hewas
found to have atrial ﬁbrillation. A CT scan of the chest with contrast
revealed small ﬁlling defects at the sub segmental level in both
lower lobes (Fig. 1) diagnostic of pulmonary embolism. No alveolar
ﬁlling was seen. The patient was treated with IV heparin and
amiodarone.He was discharged on oral anticoagulation (Rivarox-
aban). However, cough persisted and he developed daily scanty
hemoptysis with progressive breathlessness, for which he sought
attention at our institution.
On initial evaluation there was no fever or hemodynamic
instability. There was no clinical evidence of congestive heart fail-
ure. Oxygen requirements were high (90% saturation; FiO2 1.0) and
he was admitted to the intensive care unit for further evaluation
and monitoring.
Review of his occupational history revealed a 10-year history of
sandblasting without respiratory protection while working in a
automobile body shop between 1994 and 2004.
Laboratory tests showed amicrocytic hypochromic anemia (Hgb
9 g/l, MCV 78.5 ﬂ), INR 1.82, PTT 42.8, creatinine 150 mmol/L
(Normal: 55e110 mmol/L) and positive anti-myeloperoxidase
(MPO) antibodies (>200 RU/ml). Urine analysis showed: 60-80
RBC/high-powered ﬁeld, several granular casts, with a few RBC and
fatty casts. Multiple alveolar opacities were noted in both lungs on
chest radiography (Fig. 2.1).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. CT chest with contrast showing small ﬁlling defects at sub segmental left lower
lobe and right lower lobe.
Fig. 3. Heterogeneous opaciﬁcation of the lungs centrally with sparing the lung pe-
riphery diagnostic of the lung hemorrhage, with small sub pleural nodular opacities in
the upper lobes diagnostic of silicosis.
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cation of the lungs centrally with sparing of the lung periphery
consistent with a diagnosis of diffuse alveolar hemorrhage. There
were numerous small sub pleural nodules as well as mediastinal
and hilar adenopathy, consistent with a diagnosis of silicosis
(Fig. 3).
There were small bilateral pleural effusions and a moderate
pericardial effusion with contrast enhancement (Fig. 4).
Kidney ultrasound was normal. Echocardiography revealed a
moderate pericardial effusion with normal global and regional LV
systolic function. A renal biopsy revealed changes compatible with
active pauci-immue glomerulonephritis with focal and segmental
ﬁbrinoid necrosis associated with small cellular crescents (Fig. 5).
Treatment was initiated with methyl prednisone 1 g IV daily for
two days that was followed by oral prednisone 80 mg daily.Fig. 2. 1 and 2. CXR beforeCyclophosphamide 1540 mg intravenously was given as a single
dose in addition to Mesna.
There was dramatic and rapid improvement with reduction in
oxygen requirements and signiﬁcant radiographic clearing (Fig. 2.2)
over the next 4 days. The patient was transfused packed red blood
cells. The acute kidney injury persisted with elevated creatinine.
Onemonth following discharge therewas resolution of the airspace
lung opacities.
3. Discussion
Silica (silicon dioxide) exposure is the cause of silicosis. Occu-
pations at risk include miners, foundry workers, sandblasters, as
well as workers in the ceramic and glass manufacturing industries
[1,4]. There are a number of recognized complications of silica
exposure including silicosis, progressive massive ﬁbrosis, chronic
obstructive pulmonary disease, and increased risk of TB infection
and lung cancer [4,9]. Systemic complications that have been linked
to silica exposure with silicosis include: rheumatoid arthritis,and after treatment.
Fig. 4. Small bilateral pleural effusion and mild to moderate pericardial effusion with
enhancement of the pericardium.
Fig. 5. Light microscopy showing glomeruli with cellular crescents and ﬁbrin deposits.
H&E staining, 20.
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anemia, dermatomyositis or dermatopolymyositis, renal failure and
ANCA vasculitis [4,9].
Most of the studies that examine the relationship between silica
exposure and the development of systemic vasculitides have been
conducted among patients who have pulmonary silicosis
[3,6,9e11]. There is insufﬁcient evidence in the literature to support
an association of silica exposure alone, in the absence of silicosis
with systemic vasculitiides.
Silica exposure can cause dysregulation of the immune system.
Lee and colleagues showed that in menwho have chronic exposure
to silica particles, there is activation of both responder and regu-
latory T-cells leading to autoimmune dysregulation [12]. It is also
plausible that free-oxygen radicals produced from silica
stimulated-polymorphonuclear lymphocytes (PMN) could trigger a
pathway leading to endothelial damage. The interaction with silica
and the cell membrane induces the expression of myeloperoxidase
on the cell membrane of PMN's and monocytes; its subsequent
release could induce an autoimmune reaction characterized by the
development of ANCA [2].
Microscopic polyangiitis is a systemic ANCA-associated vascu-
litis that clinically and histologically affects small blood vessels
with pauci-immune necrotizing lesions affecting any organ but
especially the respiratory tract and kidney [5]. In the perinuclear
anti-neutrophil cytoplasmic antibodies (P-ANCA) vasculitis that
characterizes MPA, interstitial pneumonitis and alveolar hemor-
rhage are the two most common pulmonary manifestations [8].Workers who have had chronic exposure to silica with pulmo-
nary silicosis and with and without connective tissue disease or
vasculitis are at much greater risk of developing a wide variety of
autoantibodies including P-ANCA when compared to the normal
population [3,4,13]. Necrotizing crescentric glomerulonephritis
with P-ANCA is strongly associated with MPA [4]. This association
may depend more on the duration than on the intensity of silica
exposure [7].
That this association is more than fortuitous is suggested by the
provocative ﬁndings of Hogan and colleagues who reported in their
population-based, case-control study that high silica exposure was
found in 61 (47%) of 129 anca-associated vasculitis patients
compared to 32 (29%) of 109 control subjects (p < 0.05) [7]. In
addition, a retrospective study in one institution looked at the
prevalence of connective tissue disorders in patients who had
silicosis between 1985 and 2006 and found a 24-fold increased risk
of scleroderma and ANCA-associated vasculitis [3]. Rapidly pro-
gressive glomerulonephritis (GN) with ANCA positivity with and
without evidence for systemic vasculitis has also been reported in
silica-exposed individuals [4].
In addition to alveolar hemorrhage and glomerulonephritis, our
patient had pleuropericarditis and pulmonary embolism. These are
uncommon manifestations of MPA. Two case reports of pericardial
effusion in this context have been published [14,15]. Pleuritis and
pleural effusion reﬂecting pulmonary involvement with MPA have
been reported in 8e15% of affected individuals [16,17].
Patients who have ANCA-associated vasculitis also have an
increased risk of developing venous thromboembolism especially
during the active phase of disease [18].The increased risk has been
hypothesized to result from endothelial changes and hypercoagu-
lability caused by ANCA-vasculitis and its treatment [18e20].
In conclusion, we report a patient with silicosis and compli-
cating microscopic polyangiitis characterized by lung hemorrhage,
rapidly progressive glomerulonephritis pleuropericarditis and
pulmonary embolism. This report strengthens the evidence sup-
porting the causality of this association and reinforces the need for
obtaining a detailed work history in patients who have systemic
vasculitis.
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